{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15"}]}],"title":"Grade II acute GVHD"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Grade III acute GVHD"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Grade IV acute GVHD"}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"description":"Number of patients with acute GVHD grades II-IV","groups":[{"description":"All participants in single arm study received CD45RA+ T cell depletion PBSC transplant and IV Methotrexate and tacrolimus for GVHD prophylaxis","id":"OG000","title":"Overall Study Patients"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Up to day 100","title":"Acute GVHD Grades II-IV","type":"SECONDARY","unitOfMeasure":"Participants"}